Key result
Systemic anticoagulation with Warfarin successfully managed idiopathic pulmonary vein thrombosis in a 68-year-old woman presenting with dyspnea and hypoxia.
Why the study?
Pulmonary vein thrombosis is an uncommon and potentially fatal condition whose incidence and prevalence remain unclear, with idiopathic presentation being particularly rare.
Case Report (n=1)
Systemic anticoagulation with Warfarin can successfully treat spontaneous idiopathic pulmonary vein thrombosis.
May support warfarin in idiopathic pulmonary vein thrombosis; hypothesis-generating and requires prospective confirmation before practice change.
Pulmonary veins (PVs) are the most proximal source of arterial thromboembolism. Pulmonary vein thrombosis (PVT) is an uncommon clinical condition that can be fatal. Its incidence or prevalence is unclear as existing cases are case reports. It is often seen as a complication of malignancy, lobectomy, atrial fibrillation and less commonly idiopathic. It can be diagnosed using different types of non-invasive imaging studies. We present a 68-year-old woman who was undergoing treatment for recurrent urinary tract infection (UTI) but was incidentally noted to be dyspneic and intermittently hypoxic. She was found to have idiopathic pulmonary vein thrombosis that was successfully managed with systemic anticoagulation.
No takes yet. Share an insight, caveat, or question.
Nnodum et al. (2019) conducted a case report in Idiopathic pulmonary vein thrombosis (n=1). Systemic anticoagulation (Warfarin) was evaluated on Successful management of idiopathic pulmonary vein thrombosis. Systemic anticoagulation with Warfarin successfully managed idiopathic pulmonary vein thrombosis in a 68-year-old woman presenting with dyspnea and hypoxia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: